Wang Tao, Chan Chung Ming, Yu Feng, Li Yuan, Niu Xiaohui
Department of Orthopaedic Oncology, Beijing Ji Shui Tan Hospital, Peking University, No. 31 Xin Jie Kou Dong Jie, Xi Cheng District, Beijing, 100035, P. R. China.
Division of Orthopaedic Oncology, Department of Orthopaedics and Rehabilitation, University of Florida, Gainesville, FL, USA.
Clin Orthop Relat Res. 2017 Mar;475(3):767-775. doi: 10.1007/s11999-015-4678-y.
Many techniques have been described for reconstruction after distal radius resection for giant cell tumor with none being clearly superior. The favored technique at our institution is total wrist fusion with autogenous nonvascularized structural iliac crest bone graft because it is structurally robust, avoids the complications associated with obtaining autologous fibula graft, and is useful in areas where bone banks are not available. However, the success of arthrodesis and the functional outcomes with this approach, to our knowledge, have only been limitedly reported.
QUESTIONS/PURPOSES: (1) What is the success of union of these grafts and how long does it take? (2) How effective is the technique in achieving tumor control? (3) What complications occur with this type of arthrodesis? (4) What are the functional results of wrist arthrodesis by this technique for treating giant cell tumor of the distal radius?
Between 2005 and 2013, 48 patients were treated for biopsy-confirmed Campanacci Grade III giant cell tumor of the distal radius. Of those, 39 (81% [39 of 48]) were treated with wrist arthrodesis using autogenous nonvascularized iliac crest bone graft. Of those, 27 (69% [27 of 39]) were available for followup at a minimum of 24 months (mean, 45 months; range, 24-103 months). During that period, the general indications for this approach were Campanacci Grade III and estimated resection length of 8 cm or less. Followup included clinical and radiographic assessment and functional assessment using the Disabilities of the Arm, Shoulder and Hand (DASH) score, the Musculoskeletal Tumor Society (MSTS) score, grip strength, and range of motion at every followup by the treating surgeon and his team. All functional results were from the latest followup of each patient.
Union of the distal junction occurred at a mean of 4 months (± 2 months) and union of the proximal junction occurred at a mean of 9 months (± 5 months). Accounting for competing events, at 12 months, the rate of proximal junction union was 56% (95% confidence interval [CI], 35%-72%), whereas it was 67% (95% CI, 45%-82%) at 18 months. In total, 11 of the 27 patients (41%) underwent repeat surgery on the distal radius, including eight patients (30%) who had complications and three (11%) who had local recurrence. The mean DASH score was 9 (± 7) (value range, 0-100, with lower scores representing better function), and the mean MSTS 1987 score was 29 (± 1) (value range, 0-30, with higher scores representing better function) as well as 96% (± 4%) of mean MSTS 1993 score (value range, 0%-100%, with higher scores representing better function). The mean grip strength was 51% (± 23%) of the uninvolved side, whereas the mean arc of forearm rotation was 113° (± 49°).
Reconstruction of defects after resection of giant cell tumor of the distal radius with autogenous structural iliac crest bone graft is a facile technique that can be used to achieve favorable functional results with complications and recurrences comparable to those of other reported techniques. We cannot show that this technique is superior to other options, but it seems to be a reasonable option to consider when other reconstruction options such as allografts are not available.
Level IV, therapeutic study.
对于桡骨远端骨巨细胞瘤切除术后的重建,已有多种技术被描述,但尚无一种明显优于其他技术。我们机构所青睐的技术是采用自体非血管化髂嵴结构性骨移植进行全腕关节融合,因为它结构稳固,避免了获取自体腓骨移植相关的并发症,并且在骨库不可用的地区也适用。然而,据我们所知,这种方法的关节融合成功率及功能结果仅有有限的报道。
问题/目的:(1)这些移植骨的融合成功率如何以及需要多长时间?(2)该技术在实现肿瘤控制方面的效果如何?(3)这种类型的关节融合会出现哪些并发症?(4)通过这种技术进行腕关节融合治疗桡骨远端骨巨细胞瘤的功能结果如何?
2005年至2013年期间,48例经活检确诊为桡骨远端Campanacci III级骨巨细胞瘤的患者接受了治疗。其中,39例(81%[48例中的39例])采用自体非血管化髂嵴骨移植进行腕关节融合治疗。其中,27例(69%[39例中的27例])至少随访了24个月(平均45个月;范围24 - 103个月)。在此期间,该方法的一般适应证为Campanacci III级且估计切除长度为8 cm或更短。随访包括临床和影像学评估以及使用手臂、肩部和手部功能障碍(DASH)评分、肌肉骨骼肿瘤学会(MSTS)评分、握力以及每次随访时由主刀医生及其团队进行的活动范围评估。所有功能结果均来自每位患者的最新随访。
远端融合平均在4个月(±2个月)时发生,近端融合平均在9个月(±5个月)时发生。考虑到竞争事件,在12个月时,近端融合率为56%(95%置信区间[CI],35% - 72%),而在18个月时为67%(95%CI,45% - 82%)。27例患者中共有11例(41%)接受了桡骨远端的再次手术,包括8例(30%)出现并发症的患者和3例(11%)局部复发的患者。平均DASH评分为9(±7)(取值范围0 - 100,分数越低功能越好),平均MSTS 1987评分为29(±1)(取值范围0 - 30,分数越高功能越好)以及平均MSTS 1993评分为96%(±4%)(取值范围0% - 100%,分数越高功能越好)。平均握力为健侧的51%(±23%),而前臂平均旋转弧为113°(±49°)。
采用自体髂嵴结构性骨移植重建桡骨远端骨巨细胞瘤切除后的缺损是一种简便的技术,可用于获得良好的功能结果,其并发症和复发情况与其他报道的技术相当。我们无法证明该技术优于其他选择,但当诸如异体骨移植等其他重建选择不可用时,它似乎是一个值得考虑的合理选择。
IV级,治疗性研究。